<DOC>
	<DOCNO>NCT02627118</DOCNO>
	<brief_summary>The aim study identify hepatic enzyme estrogen-dependent biochemical change occur dialysis patient treat dialyzer know leach BPA ( Bisphenol-A ) blood , commercially available Fresenius F160NR , compare chemical evaluation patient treat non BPA contain ELISIO-15H dialyzer . Evaluations patient 's chemistry obtain prior 2 month standard dialysis treatment dialyzer .</brief_summary>
	<brief_title>Potential Effect Dialyzer Leaching BPA From Fresenius Optiflux 160NR Compared Nipro ELISIO-15H</brief_title>
	<detailed_description>The investigator propose elucidate eventual biochemical change , particular , vivo estrogenic activity BPA ( Bisphenol-A ) , BPA leach circulation Fresenius Optiflux 160NR dialyzer oppose biochemical change BPA leach , non-BPA contain Nipro Elisio 15H Polynephron dialyzer . The estrogen dependent biochemical end point human include free testosterone , sex hormone bind globulin ( SHBG ) thyroid bind globulin ( TBG )</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Male ESRD patient 18 year older Stable hemodialysis 3 month Stable hematocrit equal 29 % Stable vascular access Stable anticoagulation No active infection Able sign inform consent able participate study Medically stable â€¢ Participation another study may interfere plan study Active infection Medical condition may interfere study ( unstable cardiac status , chronic liver disease , active hepatitis define elevate liver enzymes ) Females ( expect potential change estrogenic activity might see patient expose BPA modest would mask naturally occur variability estrogen activity woman vary stage gonadal activity ( pre , postmenopausal , different point menstrual cycle , eventual pregnancy , etc ) . Thus , limit study adult male maximize possibility detecting change estrogenic activity . )</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>